“…This article clearly articulates a framework for treatment approaches that may be more successful in pediatric FNDs and it discusses results of a recently completed randomized controlled trial of “retraining and control therapy (ReACT)” in children and adolescents in whom psychiatric comorbidities are less frequently observed than in adults [8] , [9] . This and another article in this special issue highlight the differences in etiologies, treatment targets, and therapeutic interventions between pediatric and adult FNDs [8] , [10] . Finally, Dr. Stager and colleagues provide needed data on the long-term outcome of ReACT for the treatment of pediatric and adolescent FS – a bottom-up, cognitive behaviorally based, mind–body intervention that targets novel mechanisms for pediatric FS including sense of control and catastrophic symptom expectations [11] , [12] .…”